Skip to Content
BiomedicinesBiomedicines
  • Correction
  • Open Access

20 October 2025

Correction: Damiański et al. Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study. Biomedicines 2025, 13, 887

,
,
,
,
,
,
,
,
and
1
Clinical Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, 90-419 Lodz, Poland
2
Department of Pneumology, Medical University of Lodz, 90-419 Lodz, Poland
3
Center for Allergy Research, Karolinska Institutet, SE-171 77 Stockholm, Sweden
*
Author to whom correspondence should be addressed.

Error in Figure

In the original publication [1], there was a mistake in Figure 1b as published. In the section of the figure corresponding to ACQ < 1.5, the values are currently presented incorrectly. According to the text above the figure, the correct values should be “achieved: 33%”, “not achieved: 67%”.
The corrected Figure 1b appears below:
Figure 1. Panel (a) presents the proportion of patients meeting the criteria for clinical remission, clinical response, or classified as non-responders (%). Panel (b) illustrates the individual components of the disease remission criteria after one year of BENRA therapy (expressed as %).
Figure 1. Panel (a) presents the proportion of patients meeting the criteria for clinical remission, clinical response, or classified as non-responders (%). Panel (b) illustrates the individual components of the disease remission criteria after one year of BENRA therapy (expressed as %).
Biomedicines 13 02549 g001
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Damiański, P.; Białas, A.J.; Kołacińska-Flont, M.; Elgalal, A.; Jarmakowska, K.; Kierszniewska, D.; Panek, M.; Kardas, G.; Kuna, P.; Kupczyk, M. Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study. Biomedicines 2025, 13, 887. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.